Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Neoleukin Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$3.625 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$3.70 | 0 |
| Dec 2023 | $0.00 | $0.00 - $0.00 | $0.00 | -$3.267 | 0 |
| Dec 2022 | $0.00 | $0.00 - $0.00 | $0.00 | -$4.41 | 0 |
| Dec 2018 | $169.67M | $169.67M - $169.67M | -$33.93M | $1.78 | 0 |